PS1485 TRAMETINIB RESTORES IMMUNE TOLERANCE IN ITP PATIENTS BY MODULATING IRF4-MEDIATED TH1 AND TREG CELLS

Wang, H.; An, Ning; Liu, Y.; Hu, X.; Hou, M.

doi:10.1097/01.hs9.0000564200.10394.84

Download

Article (Scientific journals)

PS1485 TRAMETINIB RESTORES IMMUNE TOLERANCE IN ITP PATIENTS BY MODULATING IRF4-MEDIATED TH1 AND TREG CELLS

Wang, H.; An, Ning; Liu, Y. et al.

2019 • In HemaSphere, 3 (S1), p. 684-685

Peer Reviewed verified by ORBi

Permalink
https://hdl.handle.net/2268/291002

DOI
10.1097/01.hs9.0000564200.10394.84

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

1-s2.0-S0360301619322370-main.pdf

Author postprint (403.73 kB)

Download

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Keywords :

Hematology

Disciplines :

Hematology

Author, co-author :

Wang, H.

An, Ning ; Université de Liège - ULiège > GIGA > GIGA Stem Cells - Cancer Signaling

Liu, Y.

Hu, X.

Hou, M.

Language :

English

Title :

PS1485 TRAMETINIB RESTORES IMMUNE TOLERANCE IN ITP PATIENTS BY MODULATING IRF4-MEDIATED TH1 AND TREG CELLS

Publication date :

June 2019

Journal title :

HemaSphere

eISSN :

2572-9241

Publisher :

Ovid Technologies (Wolters Kluwer Health)

Volume :

Issue :

Pages :

684-685

Peer reviewed :

Peer Reviewed verified by ORBi

Additional URL :

https://journals.lww.com/02014419-201906001-01366

Available on ORBi :

since 20 May 2022

Statistics

Number of views

26 (2 by ULiège)

Number of downloads

24 (0 by ULiège)

More statistics

OpenCitations

OpenAlex citations